We are live on ! Find out more
IART icon

Integra LifeSciences
IART

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46% → 90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264 → 261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$140M
2
EVM
Eaton Vance Management
Massachusetts
+$75M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$20.8M
5
Morgan Stanley
Morgan Stanley
New York
+$14.4M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$55.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$35.3M
3
CB
Cooke & Bieler
Pennsylvania
-$26.1M
4
Norges Bank
Norges Bank
Norway
-$17.2M
5
Jennison Associates
Jennison Associates
New York
-$12.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
ST
226
Sageworth Trust
Pennsylvania
$12K – – –
IA
227
IFP Advisors
Florida
$11K – – –
LC
228
Lindbrook Capital
California
$11K – – –
PCG
229
Private Capital Group
Connecticut
$9K – – –
ST
230
Smithfield Trust
Pennsylvania
$9K – – –
S
231
SignatureFD
Georgia
$9K +$565 +8 +6%
CAGAS
232
Capital Advisory Group Advisory Services
Minnesota
$8K – – –
GRP
233
Global Retirement Partners
California
$8K +$8.34K +118 New
FRA
234
Front Row Advisors
California
$6K – – –
GAM
235
Gemmer Asset Management
California
$6K – – –
Nisa Investment Advisors
236
Nisa Investment Advisors
Missouri
$5.89K +$4.34M +61,424 +250%
BWM
237
BerganKDV Wealth Management
Minnesota
$5K – – –
TWA
238
TCI Wealth Advisors
Arizona
$5K – – –
HR
239
Howe & Rusling
New York
$5K +$1.27K +18 +37%
BIA
240
Bell Investment Advisors
California
$5K +$5.16K +73 New
PA
241
Parallel Advisors
California
$4K +$1.27K +18 +44%
CFA
242
Cahill Financial Advisors
Minnesota
$4K +$4.17K +59 New
FPS
243
Fieldpoint Private Securities
Connecticut
$3K – – –
MPWT
244
MassMutual Private Wealth & Trust
Connecticut
$3K +$2.61K +37 New
GFPC
245
Global Financial Private Client
Florida
$2.64K – – –
HPC
246
HM Payson & Co
Maine
$2K – – –
JFGIW
247
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$2K – – –
PFBT
248
Parkside Financial Bank & Trust
Missouri
$2K – – –
PMFA
249
Plante Moran Financial Advisors
Michigan
$2K – – –
ACM
250
AUA Capital Management
Pennsylvania
$2K +$989 +14 +70%
8 9
10
11 12

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.